The Journal of Immunology, Vol 150, Issue 3 753-762, Copyright © 1993 by American Association of Immunologists

ARTICLES

Role of peripheral hemopoietic chimerism in achieving donor-specific tolerance in adult mice

T Maeda, M Eto, Y Nishimura, K Nomoto, YY Kong and K Nomoto
Department of Immunology, Kyushu University, Fukuoka, Japan.

The role of peripheral hemopoietic chimerism in the induction and maintenance of donor-specific tolerance was investigated by our tolerance-inducing method using cyclophosphamide (CP). As has been previously reported, CP injection at a dose of 200 mg/kg to C3H (Thy- 1.2, Mls-1b) mice 2 days after priming with 10(8) viable AKR (Thy-1.1, Mls-1a) spleen cells (SC) resulted in both establishment of mixed chimerism and selective elimination of V beta 6+CD4+ T cells in the periphery. When, instead of viable SC, 1300 rad irradiated 10(8) AKR SC were used for priming to C3H mice, CP treatment 2 days after the priming also caused significant but, as compared with priming with nonirradiated viable cells, incomplete elimination of V beta 6+ T cells in the periphery. In these mice, no hemopoietic chimerism was found. In parallel with this incomplete elimination of peripheral V beta 6+ T cells, LN cells of these mice showed reduced but considerable response to AKR SC. However, once hemopoietic chimerism was introduced to these incompletely tolerant mice by an injection with donor-type viable [AKR x C3H]F1 SC 2 days after CP-treatment, LN cells from these newly established chimeras, irrespective of presence or absence of the thymus, became completely nonresponsive to AKR while preserving normal response to BALB/c (third party). This state of nonresponsiveness was accompanied by clonal elimination of the remaining V beta 6+ T cells in the periphery. These results indicate that peripheral chimerism promoted profound tolerance to donor-Mls Ag specifically. Furthermore, from experiments of skin grafting, we demonstrated that tolerance to minor histocompatibility Ag was also achieved in the presence of peripheral hemopoietic chimerism.

This article has been cited by other articles:

				T. Iwai, Y. Tomita, S. Okano, I. Shimizu, Y. Yasunami, T. Kajiwara, Y. Yoshikai, M. Taniguchi, K. Nomoto, and H. Yasui Regulatory Roles of NKT Cells in the Induction and Maintenance of Cyclophosphamide-Induced Tolerance J. Immunol., December 15, 2006; 177(12): 8400 - 8409. [Abstract] [Full Text] [PDF]

				C. Berger, M.-L. Huang, M. Gough, P. D. Greenberg, S. R. Riddell, and H.-P. Kiem Nonmyeloablative Immunosuppressive Regimen Prolongs In Vivo Persistence of Gene-Modified Autologous T Cells in a Nonhuman Primate Model J. Virol., January 15, 2001; 75(2): 799 - 808. [Abstract] [Full Text]

				Y. Tomita, M. Yoshikawa, Q.-W. Zhang, I. Shimizu, S. Okano, T. Iwai, H. Yasui, and K. Nomoto Induction of Permanent Mixed Chimerism and Skin Allograft Tolerance Across Fully MHC-Mismatched Barriers by the Additional Myelosuppressive Treatments in Mice Primed with Allogeneic Spleen Cells Followed by Cyclophosphamide J. Immunol., July 1, 2000; 165(1): 34 - 41. [Abstract] [Full Text] [PDF]